NCT05062655

Interest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge

Nterest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 130 (estimated)
• Sponsor: Centre Hospitalier le Mans · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

From a regulatory point of view, medication reconciliation is a necessary process to ensure safe medication management for patients. According to national studies and the international scientific literature, the information received by patients and health professionals at discharge from hospital is insufficient. Medication reconciliation at discharge reduces medication errors and rehospitalisation, but few studies have been conducted on the impact of a coordinated and reliable care pathway on medication continuity. The iCoCon study will enable a new healthcare organisation to be set up in order to improve the quality of the patient pathway and the patient's medication management. This new organisation is part of the policy of continuous improvement of the quality and safety of care

Conditions

• Hospitalized Patient

Interventions

Type	Name	Description
OTHER	Drug reconciliation	Drug reconciliation information transmission to pharmacist interview with the patient

Timeline

• Start date: 2021-08-03
• Primary completion: 2022-12-08
• Completion: 2022-12-08
• First posted: 2021-09-30
• Last updated: 2022-01-24

Locations

1 site across 1 country: France